drugset / Trial / NCT04633213
A Study Evaluating HBM9036 Efficacy and Safety on Moderate to Severe Dry Eye
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The objective of this study is to compare the safety and efficacy of 0.25% HBM9036 (HL036) Ophthalmic Solution to placebo for the treatment of the Chinese subjects with moderate and severe dry eye.
Timeline
- Start
- 2021-02-25
- Primary completion
- 2022-08-07
- Completion
- 2022-08-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | HBM9036 | Protein / enzyme biologic | 0.25 % | Topical |